Research map: Tofogliflozin alters amino acid metabolism in gut microbiota linked to hepatic transcriptomic signatures in MASLD

Back to the article

Papers in this map

  1. The Sequence Alignment/Map format and SAMtools · Heng Li · 2009 · 69162 citations · Cited by this paper
  2. Cellular Crosstalk at the Gut–Liver Interface in Liver Cirrhosis: Epithelial Barrier Failure, Bacterial Translocation and Immune Activation as a Bidirectional Network · Thomas N. Nitsotolis · 2026 · Cites this paper
  3. Clinical characteristics of acute pancreatitis in patients with inflammatory bowel disease: a nationwide survey in Japan · 2026 · Related
  4. Fast gapped-read alignment with Bowtie 2 · Ben Langmead · 2012 · 62901 citations · Cited by this paper
  5. Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nationwide multicenter study · 2026 · Related
  6. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters · Guangchuang Yu · 2012 · 39746 citations · Cited by this paper
  7. Diagnostic performance of magnifying endoscopy with third-generation narrow-band imaging for early gastric cancer: post hoc analysis of a randomized trial (3G detection trial) · 2026 · Related
  8. Metagenomic biomarker discovery and explanation · Nicola Segata · 2011 · 17171 citations · Cited by this paper
  9. Comment on “Intestinal obstruction impairs the antitumor function of hepatic natural killer cells against colorectal cancer” · 2026 · Related
  10. Design and validation of a histological scoring system for nonalcoholic fatty liver disease† · David Erwin Kleiner · 2005 · 10909 citations · Cited by this paper
  11. Clinical applications of gut microbiome for non-invasive diagnosis of colorectal neoplasia · 2026 · Related
  12. Diet rapidly and reproducibly alters the human gut microbiome · Lawrence A. David · 2013 · 10486 citations · Cited by this paper
  13. Dependence-related screening positivity among regular stimulant-laxative users with chronic constipation: a multicenter prospective observational study · 2026 · Related
  14. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention · Zobair M. Younossi · 2017 · 5363 citations · Cited by this paper
  15. A modified Delphi consensus on fusion (laparoscopic and robotic) approaches to colorectal surgery in Asia–Pacific · 2026 · Related
  16. Controlling the false discovery rate in behavior genetics research · Yoav Benjamini · 2001 · 4273 citations · Cited by this paper
  17. HOXC9 enhances cholesterol metabolism and malignancy in pancreatic ductal adenocarcinoma through ITGA10/FAK/PI3K/CREB-dependent HMGCR activation · 2026 · Related
  18. Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions · Elizabeth M. Brunt · 1999 · 3891 citations · Cited by this paper
  19. Vonoprazan is associated with a phenotype-specific increase in cholangitis reporting in immune checkpoint inhibitor-treated patients: a VigiBase pharmacovigilance study · 2026 · Related
  20. Multivariable association discovery in population-scale meta-omics studies · Himel Mallick · 2021 · 2603 citations · Cited by this paper
  21. Evidence-based clinical practice guidelines for metabolic dysfunction-associated steatotic liver disease (MASLD) 2026 · 2026 · Related
  22. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease · Mary Eugenia Rinella · 2023 · 2555 citations · Cited by this paper
  23. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study · Matthew James Armstrong · 2015 · 2191 citations · Cited by this paper
  24. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) · Frank Tacke · 2024 · 2049 citations · Cited by this paper
  25. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention · Daniel Q. Huang · 2020 · 1884 citations · Cited by this paper
  26. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders · Judith Aron‐Wisnewsky · 2020 · 1093 citations · Cited by this paper
  27. Global epidemiology of cirrhosis — aetiology, trends and predictions · Daniel Q. Huang · 2023 · 841 citations · Cited by this paper
  28. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women · Lesley Hoyles · 2018 · 730 citations · Cited by this paper
  29. Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial) · Mohammad Shafi Kuchay · 2018 · 655 citations · Cited by this paper
  30. High-Glucose or -Fructose Diet Cause Changes of the Gut Microbiota and Metabolic Disorders in Mice without Body Weight Change · Moon Ho Do · 2018 · 449 citations · Cited by this paper
  31. Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition · Giulia Ferrannini · 2015 · 368 citations · Cited by this paper
  32. SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice · Dustin M. Lee · 2018 · 249 citations · Cited by this paper
  33. The deleterious metabolic and genotoxic effects of the bacterial metabolite p-cresol on colonic epithelial cells · Mireille Andriamihaja · 2015 · 166 citations · Cited by this paper
  34. Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammation · Chi Kin Wong · 2022 · 135 citations · Cited by this paper
  35. Comparison of Tofogliflozin and Glimepiride Effects on Nonalcoholic Fatty Liver Disease in Participants With Type 2 Diabetes: A Randomized, 48-Week, Open-Label, Active-Controlled Trial · Yumie Takeshita · 2022 · 122 citations · Cited by this paper
  36. Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes · Xinru Deng · 2022 · 120 citations · Cited by this paper
  37. Automated precolumn derivatization system for analyzing physiological amino acids by liquid chromatography/mass spectrometry · Kazutaka Shimbo · 2009 · 119 citations · Cited by this paper
  38. Histological Course of Nonalcoholic Fatty Liver Disease in Japanese Patients · Erika Hamaguchi · 2009 · 102 citations · Cited by this paper
  39. Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma · Harry Cheuk-Hay Lau · 2025 · 81 citations · Cited by this paper

Source: OpenAlex (CC0)